Assessmment of survival and toxicity of hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma : A phase III randomized trial
JavaScript is disabled for your browser. Some features of this site may not work without it.
Assessmment of survival and toxicity of hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma : A phase III randomized trial